85 related articles for article (PubMed ID: 8494096)
21. Lack of effect of vitamin E on serum creatine phosphokinase in patients with long-term tardive dyskinesia.
Dorevitch A; Lerner V; Shalfman M; Kalian M
Int Clin Psychopharmacol; 1997 May; 12(3):171-3. PubMed ID: 9248874
[TBL] [Abstract][Full Text] [Related]
22. Successful treatment of tardive oculogyric spasms with vitamin E.
Coupland N; Nutt O
J Clin Psychopharmacol; 1995 Aug; 15(4):285-6. PubMed ID: 7593713
[No Abstract] [Full Text] [Related]
23. Alpha-tocopherol in tardive dyskinesia.
Lohr JB; Cadet JL; Lohr MA; Jeste DV; Wyatt RJ
Lancet; 1987 Apr; 1(8538):913-4. PubMed ID: 2882306
[No Abstract] [Full Text] [Related]
24. Vitamin E in the treatment of tardive dyskinesia: a replication study.
Lam LC; Chiu HF; Hung SF
J Nerv Ment Dis; 1994 Feb; 182(2):113-4. PubMed ID: 8308529
[No Abstract] [Full Text] [Related]
25. alpha-Tocopherol treatment for tardive dyskinesia.
Spivak B; Schwartz B; Radwan M; Weizman A
J Nerv Ment Dis; 1992 Jun; 180(6):400-1. PubMed ID: 1593277
[No Abstract] [Full Text] [Related]
26. Possible anti-oxidant and neuroprotective mechanisms of zolpidem in attenuating typical anti-psychotic-induced orofacial dyskinesia: a biochemical and neurochemical study.
Bishnoi M; Chopra K; Kulkarni SK
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1130-8. PubMed ID: 17513028
[TBL] [Abstract][Full Text] [Related]
27. Movement disorders: therapeutic role of vitamin E.
Cadet JL
Toxicol Ind Health; 1993; 9(1-2):337-47. PubMed ID: 8093421
[No Abstract] [Full Text] [Related]
28. Vitamin E slows the rate of free radical-mediated lipid peroxidation in cells.
Wagner BA; Buettner GR; Burns CP
Arch Biochem Biophys; 1996 Oct; 334(2):261-7. PubMed ID: 8900400
[TBL] [Abstract][Full Text] [Related]
29. Tardive dyskinesia revisited.
Russo DT; Bunch CL
Am J Health Syst Pharm; 1995 Oct; 52(19):2137-8. PubMed ID: 8535951
[No Abstract] [Full Text] [Related]
30. Animal models of tardive dyskinesia--a review.
Kulkarni SK; Naidu PS
Indian J Physiol Pharmacol; 2001 Apr; 45(2):148-60. PubMed ID: 11480221
[TBL] [Abstract][Full Text] [Related]
31. Effect of Withania somnifera root extract on reserpine-induced orofacial dyskinesia and cognitive dysfunction.
Naidu PS; Singh A; Kulkarni SK
Phytother Res; 2006 Feb; 20(2):140-6. PubMed ID: 16444668
[TBL] [Abstract][Full Text] [Related]
32. Clinical effectiveness of the Kampo medicine kamishoyosan for adjunctive treatment of tardive dyskinesia in patients with schizophrenia: a 16-week open trial.
Lee JG; Shin BS; Lee YC; Park SW; Kim YH
Psychiatry Clin Neurosci; 2007 Oct; 61(5):509-14. PubMed ID: 17875029
[TBL] [Abstract][Full Text] [Related]
33. Protective effect of Curcumin, the active principle of turmeric (Curcuma longa) in haloperidol-induced orofacial dyskinesia and associated behavioural, biochemical and neurochemical changes in rat brain.
Bishnoi M; Chopra K; Kulkarni SK
Pharmacol Biochem Behav; 2008 Feb; 88(4):511-22. PubMed ID: 18022680
[TBL] [Abstract][Full Text] [Related]
34. Beneficial effects of vitamin C and vitamin E on reserpine-induced oral dyskinesia in rats: critical role of striatal catalase activity.
Faria RR; Abílio VC; Grassl C; Chinen CC; Negrão LT; de Castro JP; Fukushiro DF; Rodrigues MS; Gomes PH; Registro S; de Carvalho Rde C; D'Almeida V; Silva RH; Ribeiro Rde A; Frussa-Filho R
Neuropharmacology; 2005 Jun; 48(7):993-1001. PubMed ID: 15857626
[TBL] [Abstract][Full Text] [Related]
35. Vitamin B6 in treatment of tardive dyskinesia: a preliminary case series study.
Lerner V; Kaptsan A; Miodownik C; Kotler M
Clin Neuropharmacol; 1999; 22(4):241-3. PubMed ID: 10442256
[TBL] [Abstract][Full Text] [Related]
36. Risperidone for severe tardive dyskinesia: a 12-week randomized, double-blind, placebo-controlled study.
Bai YM; Yu SC; Lin CC
J Clin Psychiatry; 2003 Nov; 64(11):1342-8. PubMed ID: 14658949
[TBL] [Abstract][Full Text] [Related]
37. Treatment of tardive dyskinesia with levetiracetam in a transplant patient.
Zivković SA; Costa G; Bond G; Abu-Elmagd KM
Acta Neurol Scand; 2008 May; 117(5):351-3. PubMed ID: 17995990
[TBL] [Abstract][Full Text] [Related]
38. Treatment of tardive dyskinesia.
N Engl J Med; 1977 Apr; 296(17):1004-5. PubMed ID: 846531
[No Abstract] [Full Text] [Related]
39. Treatment of tardive dyskinesia with propranolol.
Pitts FN
J Clin Psychiatry; 1982 Aug; 43(8):304. PubMed ID: 7096269
[No Abstract] [Full Text] [Related]
40. Rapid remission of severe tardive dyskinesia and tardive dystonia with quetiapine.
Bouckaert F; Herman G; Peuskens J
Int J Geriatr Psychiatry; 2005 Mar; 20(3):287-8. PubMed ID: 15770692
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
